title: Comment on 'Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy'.
authors.affiliation: Department of Vitreo-Retina, Dr. Agarwal's Eye Hospital, Kigali, Rwanda.
authors.forename: N V
authors.initials: NV
authors.lastname: Radke
authors.affiliation: Department of Vitreo-Retina, Vasan Eye Care Hospital, Hyderabad, India.
authors.forename: T K
authors.initials: TK
authors.lastname: Panakanti
authors.affiliation: Department of Vitreo-Retina, Dr. Agarwal's Eye Hospital, Kigali, Rwanda.
authors.forename: S N
authors.initials: SN
authors.lastname: Radke
authors.affiliation: Department of Vitreo-Retina, Vasan Eye Care Hospital, Hyderabad, India.
authors.forename: R
authors.initials: R
authors.lastname: Ravikoti
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D012163:Retinal Detachment / Q000601:surgery*; D012827:Silicone Oils / Q000008:administration & dosage*; D018630:Vitreoretinopathy, Proliferative / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D012827:Silicone Oils
references.citation: Surv Ophthalmol. 2013 Jul-Aug;58(4):321-9
references.pmid: 23642514
references.citation: Eye (Lond). 2014 May;28(5):510-20
references.pmid: 24525867
references.citation: Eye (Lond). 2014 May;28(5):576-80
references.pmid: 24556886